Status:
COMPLETED
Long Term Metformin in Women With Polycystic Ovary Syndrome
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-55 years
Brief Summary
The investigators analyzed collection data of 10 years for the efficacy of metformin on body mass, menstrual frequencies, metabolic and hormonal outcomes in women with polycystic ovary syndrome (PCOS)...
Eligibility Criteria
Inclusion
- PCOS phenotype A
- BMI≥ 25kg/m2
- metformin 1000mg twice a day for at least one year
Exclusion
- PCOS phenotype B, C, D
- BMI \<25kg/m2
- had been treated with spironolactone or oral contraceptives alone or in combination with metformin
- had history of bariatric surgery
- became pregnant during the observation period
- had inability to tolerate metformin, leading to the cessation of drug therapy within first follow up year
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04043221
Start Date
January 1 2006
End Date
January 1 2019
Last Update
August 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Ljubljana
Ljubljana, Slovenia, 1000